Table: Sawai Pharmaceutical -9-MTH group results (IFRS)

SAWAI group

14/02/2020 06:00

Feb 14 (Reuters)- 
              Sawai Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2019        Dec 31, 2018     Mar 31, 2020 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales                                                   184.40    
                                                        (+0.0 pct)  
  Sales              140.27              138.00                     
                   (+1.6 pct)          (+8.5 pct)                   
  Operating           23.94               21.90            25.80    
                   (+9.3 pct)          (+4.8 pct)       (+0.0 pct)  
  Pretax              23.79               21.83            25.70    
                   (+9.0 pct)          (+2.6 pct)       (+0.1 pct)  
  Net                 17.32               16.80            19.20    
                   (+3.1 pct)          (+7.4 pct)       (-0.9 pct)  
  EPS Basic        395.59 yen          383.87 yen       438.53 yen  
  EPS Diluted      395.27 yen          383.62 yen                   
  Ann Div                              135.00 yen       130.00 yen  
  -Q2 Div           65.00 yen           65.00 yen                   
  -Q4 Div                               70.00 yen        65.00 yen  
 
  NOTE - Sawai Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4555.T